>>> US After Hours Summary: OLLI +4.6%, FDX +3.6% rise on earnings; NKE -2.9% lo

After Hours Summary: OLLI +4.6%, FDX +3.6% rise on earnings; NKE -2.9% lower on earnings; several NFL deals signed with AMZN, FOXA, VIAC

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: ALTG +9.1%, MP +8.2%, OLLI +4.6%, FDX +3.6%

Companies trading higher in after hours in reaction to news: KNSA +8.4% (announces FDA approval of ARCALYST for recurrent pericarditis), SRPT +6.7% (shares new results from ongoing study of SRP-9003), TRIL +5.4% (files mixed securities shelf offering), LLNW +2.7% (announces actions to improve growth and profitability; announces workforce reduction), WPRT +2.1% (announces co-investment agreement with Tier 1 injector manufacturing partner to expand China production footprint), FOXA +1.5% (announces a new and expanded media rights agreement with the NFL), BTU +0.6% (announces upcoming departure of CEO), INTC +0.3% (Xe HPG DG2 discrete gaming GPUs may get revealed next week, according to TheVerge), AMZN +0.2% (signs deal with NFL for exclusive Thursday Night Football broadcasts), TSLA +0.2% (NHTSA investigating another Tesla crash in which Autopilot was allegedly used, according to TheVerge), UDR +0.1% (increases dividend)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: HIMS -6.3%, NKE -2.9%, LAZR -0.9%, TWI -0.2%

Companies trading lower in after hours in reaction to news: IDRA -65.1% (announces results from ILLUMINATE-301 trial; primary endpoint of ORR was not met), ROAD -4.6% (stock offering), UK -3.4% (stock offering), WIMI -2.6% (stock offering), NBEV -1% (stock offering), ILMN -0.9% (new chair of board), CYCN -0.7% (Chief Medical Officer departs), VTVT -0.4% (initiates study exploring the effects of TTP399 on ketone body formation; also files for $250 mln stock offering), VIAC -0.3% (signs new rights agreement with NFL; Paramount+ granted new and expanded rights for streaming, CBS to air three Super Bowls), MED -0.2% (increases dividend), INCY -0.2% (announces results from Phase 3 DEVENT trial; study did not meet its primary endpoint), EXR -0.1% (stock offering), BHLB -0.1% (new CFO), BALY -0.1% (stock offering; also files mixed securities shelf offering), GPMT -0.1% (increases dividend)